CEMTREX INC (CETX) Fundamental Analysis & Valuation

NASDAQ:CETX • US15130G8731

Current stock price

0.7525 USD
-0.01 (-1.94%)
At close:
0.74 USD
-0.01 (-1.66%)
After Hours:

This CETX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CETX Profitability Analysis

1.1 Basic Checks

  • CETX had negative earnings in the past year.
  • CETX had a positive operating cash flow in the past year.
  • In the past 5 years CETX always reported negative net income.
  • CETX had negative operating cash flow in 4 of the past 5 years.
CETX Yearly Net Income VS EBIT VS OCF VS FCFCETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M

1.2 Ratios

  • The Return On Assets of CETX (-59.34%) is worse than 83.06% of its industry peers.
  • The Return On Equity of CETX (-325.30%) is worse than 92.74% of its industry peers.
  • With a Return On Invested Capital value of 1.69%, CETX perfoms like the industry average, outperforming 51.61% of the companies in the same industry.
Industry RankSector Rank
ROA -59.34%
ROE -325.3%
ROIC 1.69%
ROA(3y)-31.62%
ROA(5y)-27.6%
ROE(3y)-199.93%
ROE(5y)-145.51%
ROIC(3y)N/A
ROIC(5y)N/A
CETX Yearly ROA, ROE, ROICCETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

  • CETX has a Operating Margin (0.67%) which is in line with its industry peers.
  • The Gross Margin of CETX (42.21%) is better than 71.77% of its industry peers.
  • CETX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.67%
PM (TTM) N/A
GM 42.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.59%
GM growth 5Y0.85%
CETX Yearly Profit, Operating, Gross MarginsCETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

1

2. CETX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CETX is destroying value.
  • The number of shares outstanding for CETX has been increased compared to 1 year ago.
  • CETX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CETX has an improved debt to assets ratio.
CETX Yearly Shares OutstandingCETX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200K 400K 600K 800K
CETX Yearly Total Debt VS Total AssetsCETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • CETX has an Altman-Z score of -1.04. This is a bad value and indicates that CETX is not financially healthy and even has some risk of bankruptcy.
  • CETX has a Altman-Z score of -1.04. This is in the lower half of the industry: CETX underperforms 79.03% of its industry peers.
  • CETX has a Debt/Equity ratio of 0.53. This is a neutral value indicating CETX is somewhat dependend on debt financing.
  • CETX has a Debt to Equity ratio of 0.53. This is in the lower half of the industry: CETX underperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF N/A
Altman-Z -1.04
ROIC/WACC0.23
WACC7.32%
CETX Yearly LT Debt VS Equity VS FCFCETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.22 indicates that CETX should not have too much problems paying its short term obligations.
  • CETX's Current ratio of 1.22 is on the low side compared to the rest of the industry. CETX is outperformed by 82.26% of its industry peers.
  • A Quick Ratio of 0.94 indicates that CETX may have some problems paying its short term obligations.
  • CETX has a Quick ratio of 0.94. This is amonst the worse of the industry: CETX underperforms 82.26% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.94
CETX Yearly Current Assets VS Current LiabilitesCETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

3

3. CETX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 97.65% over the past year.
  • The Revenue has grown by 14.39% in the past year. This is quite good.
  • CETX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.95% yearly.
EPS 1Y (TTM)97.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.62%
Revenue 1Y (TTM)14.39%
Revenue growth 3Y14.99%
Revenue growth 5Y11.95%
Sales Q2Q%2.16%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y265.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CETX Yearly Revenue VS EstimatesCETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CETX Yearly EPS VS EstimatesCETX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2023 2024 2025 2026 0 2M -2M 4M -4M -6M

4

4. CETX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CETX. In the last year negative earnings were reported.
  • CETX is valuated cheaply with a Price/Forward Earnings ratio of 0.37.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CETX indicates a rather cheap valuation: CETX is cheaper than 100.00% of the companies listed in the same industry.
  • CETX is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 0.37
CETX Price Earnings VS Forward Price EarningsCETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CETX is valued cheaper than 84.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.98
CETX Per share dataCETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150 -200

4.3 Compensation for Growth

  • CETX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. CETX Dividend Analysis

5.1 Amount

  • No dividends for CETX!.
Industry RankSector Rank
Dividend Yield 0%

CETX Fundamentals: All Metrics, Ratios and Statistics

CEMTREX INC

NASDAQ:CETX (3/13/2026, 8:14:55 PM)

After market: 0.74 -0.01 (-1.66%)

0.7525

-0.01 (-1.94%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-13
Earnings (Next)05-13
Inst Owners0.36%
Inst Owner Change9183.05%
Ins Owners0%
Ins Owner Change0%
Market Cap6.77M
Revenue(TTM)76.49M
Net Income(TTM)-28.36M
Analysts82.86
Price TargetN/A
Short Float %7.27%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.37
P/S 0.09
P/FCF N/A
P/OCF 42.51
P/B 0.78
P/tB 1.76
EV/EBITDA 9.98
EPS(TTM)-241.29
EYN/A
EPS(NY)2.05
Fwd EY272.45%
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)0.02
OCFY2.35%
SpS8.5
BVpS0.97
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -59.34%
ROE -325.3%
ROCE 2.13%
ROIC 1.69%
ROICexc 2.13%
ROICexgc 2.86%
OM 0.67%
PM (TTM) N/A
GM 42.21%
FCFM N/A
ROA(3y)-31.62%
ROA(5y)-27.6%
ROE(3y)-199.93%
ROE(5y)-145.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.59%
GM growth 5Y0.85%
F-Score5
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF N/A
Debt/EBITDA 2.46
Cap/Depr 216.16%
Cap/Sales 3.83%
Interest Coverage 0.5
Cash Conversion 8.53%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.94
Altman-Z -1.04
F-Score5
WACC7.32%
ROIC/WACC0.23
Cap/Depr(3y)194.3%
Cap/Depr(5y)152.34%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.62%
EPS Next Y265.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.39%
Revenue growth 3Y14.99%
Revenue growth 5Y11.95%
Sales Q2Q%2.16%
Revenue Next Year15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y110.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.03%
OCF growth 3YN/A
OCF growth 5YN/A

CEMTREX INC / CETX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CEMTREX INC?

ChartMill assigns a fundamental rating of 2 / 10 to CETX.


Can you provide the valuation status for CEMTREX INC?

ChartMill assigns a valuation rating of 4 / 10 to CEMTREX INC (CETX). This can be considered as Fairly Valued.


Can you provide the profitability details for CEMTREX INC?

CEMTREX INC (CETX) has a profitability rating of 2 / 10.


How financially healthy is CEMTREX INC?

The financial health rating of CEMTREX INC (CETX) is 1 / 10.


Can you provide the expected EPS growth for CETX stock?

The Earnings per Share (EPS) of CEMTREX INC (CETX) is expected to grow by 265.45% in the next year.